Skip to main content

Table 1 Demographic, anthropometric and clinical data of patients classified according to the extent of coronary lesion

From: The relationship of the oleic acid level and ECHDC3 mRNA expression with the extent of coronary lesion

Variables

Total (n = 59)

Without lesion (n = 18)

Low lesion (n = 17)

Intermediate lesion

(n = 17)

Major lesion

(n = 7)

p-value

Age, years

60.0 ± 9.0

55.0 ± 9.0

62.0 ± 9.0

63.0 ± 10

60.0 ± 7.0

0.080

Sex male, %

54.2

44.4

58.8

64.7

42.9

0.582

BMI, kg/m2

26.82 ± 5.65

27.86 ± 4.70

25.27 ± 8.52

26.92 ± 4.29

27.43 ± 1.13

0.630

Obesity, %

20.3

33.3

17.6

17.6

0

0.133

Dyslipidemia, %

91.5

77.8

100.0

94.1

100.0

0.080

Diabetes mellitus, %

30,5

33.3

23.5

35.3

28.6

0.884

Hypertension, %

79.7

77.8

76.5

82.4

85.7

0.944

Diastolic pressure, mmHg

84.0 ± 20.0

81.0 ± 8.0

80.0 ± 24.0

90.0 ± 18.0

90.0 ± 32.0

0.355

Systolic pressure, mmHg

143.0 ± 26.0

137.0 ± 24.0

139.0 ± 22.0

155.0 ± 32.0

141.0 ± 21.0

0.187

Alcoholism, %

18.6

27.8

17.6

5.9

28.6

0.350

Smoking, %

22.0

27.8

17.6

17.6

28.6

0.825

Physical activity, %

47.5

50.0

58.8

35.3

42.9

0.573

Biochemical Analyses

Glucose, mmol/l

5.16 (3.72–21.87)

4.75 (3.89–14.26)

4.88 (3.75–11.04)

5.55 (3.72–21.87)

5.94 (4.44–13.04)

0.443

Total cholesterol, mmol/l

4.61 (2.95–7.85)

4.36 (3.08–6.50)

4.51 (3.19–6.89)

5.05 (2.95–7.85)

4.61(3.65–7.02)

0.555

HDL-cholesterol, mmol/l

0.92 (0.41–1.45)

0.95 (0.57–1.45)

0.93 (0.54–1.30)

0.91 (0.41–1.32)

0.83 (0.62–1.40)

0.669

LDL-cholesterol, mmol/l

2.68 (1.21–5.74)

2.38(1.49–4.57)

2.63(1.21–5.00)

3.26 (1.21–5.74)

2.89 (1.93–5.27)

0.419

Triglycerides, mmol/l

1.62 (0.75–9.47)

1.63 (0.79–6.94)

2.25(0.86–6.96)

1.62(0.75–9.47)

1.45 (0.85–3.24)

0.612

ALT, μKat/l

0.43 (0.17–2.19)

0.38 (0.17–1.57)

0.43 (0.25–1.04)

0.33 (0.17–2.19)

0.60 (0.25–1.45)

0.723

AST, μKat/l

0.52 (0.25–1.57)

0.52 (0.25–1.49)

0.43 (0.25–0.95)

0.52 (0.25–1.57)

0.60 (0.25–1.57)

0.546

Ureia, mmol/l

5.85 (3.34–10.35)

5.93 (3.34–9.52)

5.68 (4.31–9.85)

5.93(3.37–10.35)

5.85 (4.84–6.35)

0.693

Creatinine, μmol/l

79.56 (17.68–141.44)

79.56 (53.04–141.44)

79.56(53.04–123.76)

88.40 (53.04–106.08)

70.72 (17.68–106.08)

0.323

Uric acid, mmol/l

0.29 (0.11–0.52)

0.27(0.16–0.52)

0.28 (0.11–0.43)

0.29 (0.11–0.43)

0.33 (0.14–0.37)

0.965

  1. Data are presented as mean ± standard deviation for parametric samples and as median (interquartile range) for non-parametric samples. Categorical variables were compared by Chi-square test. Parametric analysis was performed by ANOVA way. Non-parametric samples were performed by Kruskal-Wallis test. P-values < 0.05 were considered statistically significant in all statistical test. BMI body mass index, HDL-cholesterol high density lipoprotein, LDL-cholesterol low density lipoprotein, AST aspartate aminotransferase, ALT alanine transaminase